Effect of major tumor metabolites on release of doxorubicin from Doxil – implications for precision nano-medicine.
Our previous studies demonstrate that ammonia induces doxorubicin release from Doxil® in a concentration-dependent manner. Because ammonia that results from glutaminolysis is continu-ously generated in tumors at high enough concentration to induce doxorubicin release of Doxil in tumors, this may exp...
Main Authors: | Lisa Silverman, Yechezkel Barenholz |
---|---|
Format: | Article |
Language: | English |
Published: |
Andover House Inc.
2020-11-01
|
Series: | Precision Nanomedicine |
Online Access: | http://prnano.scholasticahq.com/article/17956-effect-of-major-tumor-metabolites-on-release-of-doxorubicin-from-doxil-implications-for-precision-nano-medicine.pdf |
Similar Items
-
Cardinal Role of Intraliposome Doxorubicin-Sulfate Nanorod Crystal in Doxil Properties and Performance
by: Xiaohui Wei, et al.
Published: (2018-03-01) -
Quantitative Cryo-TEM Reveals New Structural Details of Doxil-Like PEGylated Liposomal Doxorubicin Formulation
by: Rickard Nordström, et al.
Published: (2021-01-01) -
Understanding the Role of Anti-PEG Antibodies in the Complement Activation by Doxil in Vitro
by: Barry W. Neun, et al.
Published: (2018-07-01) -
Therapeutic efficacy of combining pegylated liposomal doxorubicin and radiofrequency (RF) ablation: comparison between slow-drug-releasing, non-thermosensitive and fast-drug-releasing, thermosensitive nano-liposomes.
by: Alexander V Andriyanov, et al.
Published: (2014-01-01) -
Multimodality Imaging of Tumor Response to Doxil
by: Fan Zhang, Lei Zhu, Gang Liu, Naoki Hida, Guangming Lu, Henry S. Eden, Gang Niu, Xiaoyuan Chen
Published: (2011-01-01)